Turn Therapeutics Inc. GAAP EPS of -$0.21
- Turn Therapeutics Inc. press release (TTRX): Q3 GAAP EPS of -$0.21.
- The Company had $10.4 million in cash and cash equivalents as of September 30, 2026. Based on current estimates, the Company expects its available cash to support the ongoing Phase 2b atopic dermatitis
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.